Clarity News article

Dr Colin Biggin Appointed Head of Quality at Clarity Pharmaceuticals

  Sydney, Australia 19 January 2017 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment of Dr Colin Biggin as Head of Quality at Clarity. Dr Biggin has over 15 years’ experience in radiochemistry and radiopharmaceutical development. His most recent full-time role was with Algeta…

Elsevier article

Elsevier – Start-Up Spotlight: Clarity Pharmaceuticals

Clarity Pharmaceuticals was featured in Pharma R&D Today by Elsevier, a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals. “We believe in personalized medicine and the development of new therapies that are more effective and have less side effects. At Clarity, we recognized that radiopharmaceuticals have this potential…